United States· US:53746-555_04625dca-8f81-4c33-acd2-c8c2693f8483
Demeclocycline Hydrochloride
A demeclocycline product containing demeclocycline hydrochloride, registered in United States by Amneal Pharmaceuticals of New York LLC. The same ATC class is registered in 5 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Demeclocycline is registered in 5 of 19 countries.
Countries holding a registration under ATC J01AA01 (demeclocycline), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Demeclocycline · ATC J01AA01
5 / 19 countries
- Finlandprice
- Japan
- Netherlands
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEMECLOCYCLINE HYDROCHLORIDE
- Manufacturer
- Amneal Pharmaceuticals of New York LLC
- Country
- United States (US)
- ATC code
- J01AA01
- ATC class
- Demeclocycline
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1153746-555-48
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
169 interactions on record for demeclocycline.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Demeclocycline · interactions on record
169 records
- 10 severe
- 132 moderate
- 27 minor
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- AcitretinD05BB02severe
- IsotretinoinD10AD04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Demeclocycline in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDemeclocycline 150mg capsulesA A H Pharmaceuticals Ltd
- FranceDEMECLOCYCLINE ACETLAB 150 mg, géluleMITEM PHARMA
- Japanデメチルクロルテトラサイクリン塩酸塩サンファーマ
- NetherlandsLedermycin, capsules 300 mgEurocept International B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- France · Demeclocycline Acetlab
- United Kingdom (Northern Ireland) · Demeclocycline Hydrochloride Dawa, Demeclocycline Hydrochloride Mercury Pharmaceuticals
- Netherlands · Ledermycin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eb64a9ec-ad38-441a-88a1-fce670b041e9 GET /v1/drugs/eb64a9ec-ad38-441a-88a1-fce670b041e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "300",
"substance": "DEMECLOCYCLINE HYDROCHLORIDE",
"productndc": "53746-555",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA065425",
"marketing_category": "ANDA"
}See everything about demeclocycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.